USA - New York Stock Exchange - NYSE:THC - US88033G4073 - Common Stock
The current stock price of THC is 202 USD. In the past month the price decreased by -2.09%. In the past year, price increased by 57.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 18.19 | 107.40B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 10.02 | 13.02B | ||
| EHC | ENCOMPASS HEALTH CORP | 20.57 | 10.70B | ||
| ENSG | ENSIGN GROUP INC/THE | 28.59 | 10.33B | ||
| PACS | PACS GROUP INC | 28.8 | 6.45B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.67B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.6 | 2.50B | ||
| NHC | NATIONAL HEALTHCARE CORP | 19.66 | 2.05B | ||
| SGRY | SURGERY PARTNERS INC | 20.05 | 2.02B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 17.67 | 1.88B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 5.29 | 1.26B | ||
| ARDT | ARDENT HEALTH INC | 4.22 | 1.29B |
Tenet Healthcare Corp. engages in the provision of healthcare services. The company is headquartered in Dallas, Texas and currently employs 74,480 full-time employees. The firm's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The firm's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. The company also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The firm operates a Global Business Center in the Philippines.
TENET HEALTHCARE CORP
14201 Dallas Parkway
Dallas TEXAS 75254 US
CEO: Ronald A. Rittenmeyer
Employees: 86240
Phone: 14698932200
Tenet Healthcare Corp. engages in the provision of healthcare services. The company is headquartered in Dallas, Texas and currently employs 74,480 full-time employees. The firm's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The firm's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. The company also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The firm operates a Global Business Center in the Philippines.
The current stock price of THC is 202 USD. The price decreased by -3% in the last trading session.
THC does not pay a dividend.
THC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
TENET HEALTHCARE CORP (THC) operates in the Health Care sector and the Health Care Providers & Services industry.
The PE ratio for TENET HEALTHCARE CORP (THC) is 13.02. This is based on the reported non-GAAP earnings per share of 15.52 and the current share price of 202 USD.
The outstanding short interest for TENET HEALTHCARE CORP (THC) is 3.08% of its float.
ChartMill assigns a technical rating of 6 / 10 to THC. When comparing the yearly performance of all stocks, THC is one of the better performing stocks in the market, outperforming 88.02% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to THC. THC scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months THC reported a non-GAAP Earnings per Share(EPS) of 15.52. The EPS increased by 39.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.49% | ||
| ROA | 4.6% | ||
| ROE | 33.73% | ||
| Debt/Equity | 3.26 |
28 analysts have analysed THC and the average price target is 238.92 USD. This implies a price increase of 18.28% is expected in the next year compared to the current price of 202.
For the next year, analysts expect an EPS growth of 36.76% and a revenue growth 2.31% for THC